Home›Companies›Biotech & Pharma›RNAV8 Bio

RNAV8 Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 17, 2025·Suggest an edit

About RNAV8 Bio

RNAV8 Bio is a private company based in Laguna Niguel, California, incorporated in 2022 in Delaware. It has reported $2,013,880 raised in one offering on Form D since January 2023. Its chief executive is Devan Shah.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 9, 2022Jan 4, 2023amended Mar 17, 2025$2,013,880of $3.0M target42$47,950OptionsRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RNAV8 Bio's Form D filed Mar 17, 2025.

DS
Devan Shah
Chief Executive Officer and director

Sources

  1. SECRNAV8 BIO, INC. Form D/A, filed Jun 26, 2023
  2. SECRNAV8 BIO, INC. Form D/A, filed Jan 4, 2023
  3. SECRNAV8 BIO, INC. Form D, filed Jan 4, 2023
  4. SECRNAV8 BIO, INC. filing history